Company Filing History:
Years Active: 2025
Title: Youngri Kim: Innovator in Pharmaceutical Formulations
Introduction
Youngri Kim is a notable inventor based in Anaheim, California. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative formulations. His work focuses on enhancing the efficacy of nucleoside analogs, which are crucial in various therapeutic applications.
Latest Patents
Youngri Kim holds a patent for "Phospholipid formulations of 1'-cyano substituted carba-nucleoside analogs." This patent provides pharmaceutical formulations of a specific compound or its pharmaceutically acceptable salt. His innovative approach aims to improve the delivery and effectiveness of these compounds in medical treatments.
Career Highlights
Currently, Youngri Kim is employed at Gilead Sciences, Inc., a leading biopharmaceutical company known for its focus on antiviral drugs. His role at Gilead allows him to work on cutting-edge research and development projects that aim to address significant health challenges.
Collaborations
Throughout his career, Youngri Kim has collaborated with talented professionals, including Gerard Jensen and Kian Yong Lee. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
Youngri Kim's contributions to pharmaceutical formulations exemplify the impact of innovative thinking in medicine. His work continues to influence the development of effective treatments, showcasing the importance of research and collaboration in the field.